Zomedica Statistics
Total Valuation
Zomedica has a market cap or net worth of $128.37 million. The enterprise value is $53.77 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Zomedica has 979.95 million shares outstanding.
| Current Share Class | 979.95M |
| Shares Outstanding | 979.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.73% |
| Owned by Institutions (%) | 8.26% |
| Float | 961.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.81 |
| Forward PS | 14.36 |
| PB Ratio | 0.63 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.82, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.82 |
| Quick Ratio | 9.83 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.82% and return on invested capital (ROIC) is -10.23%.
| Return on Equity (ROE) | -26.82% |
| Return on Assets (ROA) | -9.78% |
| Return on Capital (ROIC) | -10.23% |
| Revenue Per Employee | $185,604 |
| Profits Per Employee | -$431,903 |
| Employee Count | 144 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 1.77 |
Taxes
In the past 12 months, Zomedica has paid $123,000 in taxes.
| Income Tax | 123,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.60% in the last 52 weeks. The beta is 1.06, so Zomedica's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -21.60% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 53.20 |
| Average Volume (20 Days) | 7,315,822 |
Short Selling Information
The latest short interest is 51.14 million, so 5.22% of the outstanding shares have been sold short.
| Short Interest | 51.14M |
| Short Previous Month | 43.37M |
| Short % of Shares Out | 5.22% |
| Short % of Float | 5.32% |
| Short Ratio (days to cover) | 17.24 |
Income Statement
In the last 12 months, Zomedica had revenue of $26.73 million and -$62.19 million in losses. Loss per share was -$0.06.
| Revenue | 26.73M |
| Gross Profit | 18.61M |
| Operating Income | -38.26M |
| Pretax Income | -38.47M |
| Net Income | -62.19M |
| EBITDA | -30.45M |
| EBIT | -38.26M |
| Loss Per Share | -$0.06 |
Full Income StatementBalance Sheet
The company has $76.88 million in cash and $2.08 million in debt, giving a net cash position of $74.80 million or $0.08 per share.
| Cash & Cash Equivalents | 76.88M |
| Total Debt | 2.08M |
| Net Cash | 74.80M |
| Net Cash Per Share | $0.08 |
| Equity (Book Value) | 202.84M |
| Book Value Per Share | 0.21 |
| Working Capital | 79.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$24.12 million and capital expenditures -$6.67 million, giving a free cash flow of -$30.79 million.
| Operating Cash Flow | -24.12M |
| Capital Expenditures | -6.67M |
| Free Cash Flow | -30.79M |
| FCF Per Share | -$0.03 |
Full Cash Flow StatementMargins
Gross margin is 69.64%, with operating and profit margins of -143.14% and -232.70%.
| Gross Margin | 69.64% |
| Operating Margin | -143.14% |
| Pretax Margin | -232.24% |
| Profit Margin | -232.70% |
| EBITDA Margin | -113.94% |
| EBIT Margin | -143.14% |
| FCF Margin | -123.28% |